Author(s): Maulikkumar D. Vaja, Ruchita R. Patel, Bhoomi D. Patel, Ankit B. Chaudhary

Email(s): maulikvaja@yahoo.in

DOI: 10.52711/0974-360X.2022.00840   

Address: Maulikkumar D. Vaja1*, Ruchita R. Patel2, Bhoomi D. Patel3, Ankit B. Chaudhary4
1Associate Professor, Saraswati Institute of Pharmaceutical Sciences, Dhanap, Gandhinagar, Gujarat, India – 382355.
2Student, Saraswati Institute of Pharmaceutical Sciences, Dhanap, Gandhinagar, Gujarat, India – 382355.
3Associate Professor, Saraswati Institute of Pharmaceutical Sciences, Dhanap, Gandhinagar, Gujarat, India – 382355.
4Principal and Professor, Saraswati Institute of Pharmaceutical Sciences, Dhanap, Gandhinagar, Gujarat, India – 382355.
*Corresponding Author

Published In:   Volume - 15,      Issue - 11,     Year - 2022


ABSTRACT:
Objective: The aim of the present work is the development of new, sensitive, specific, and accurate high-performance liquid chromatographic method for the Estimation of Lurasidone and its Impurities Lurasidone 1 and Lurasidone 8. Methods: The chromatographic separation of drug and its impurities was achieved using Inertsil ODS C18 column (150mm x 4.6mm, 5µm) with mobile phase consisted of mobile phase-A 0.05M Potassium Dihydrogen Phosphate buffer (pH- 4.0, adjusted with 1% Orthophosphoric acid) and mobile phase-B Acetonitrile in the ratio of 60:40 % v/v at a flow rate of 1.0 ml/min with ultraviolet detection at 230 nm. Results: Lurasidone and its Impurities Lurasidone 1 and Lurasidone 8 were successfully eluted at the retention time of 6.022, 5.024 and 10.456 min respectively, with good resolution. The described method was linear over a concentration range of 160-1200 µg/ml for Lurasidone, 1.6-12 µg/ml for Lurasidone 1 and Lurasidone 8. The % recoveries of Lurasidone was found to be 100.565% - 101.061%. The method was validated according to the international conference on harmonization guidelines. The validation results showed good precision, accuracy, linearity, specificity, sensitivity, and robustness. Conclusion: Successful separation and Estimation of Lurasidone and its Impurities Lurasidone 1 and Lurasidone 8 were achieved by the proposed method. The developed method can be applied for the routine analysis of Lurasidone and its impurities in pharmaceutical formulations.


Cite this article:
Maulikkumar D. Vaja, Ruchita R. Patel, Bhoomi D. Patel, Ankit B. Chaudhary. Development and Validation of RP-HPLC Method for Estimation of Lurasidone and its impurities Lurasidone 1 and Lurasidone 8. Research Journal of Pharmacy and Technology. 2022; 15(11):4999-4. doi: 10.52711/0974-360X.2022.00840

Cite(Electronic):
Maulikkumar D. Vaja, Ruchita R. Patel, Bhoomi D. Patel, Ankit B. Chaudhary. Development and Validation of RP-HPLC Method for Estimation of Lurasidone and its impurities Lurasidone 1 and Lurasidone 8. Research Journal of Pharmacy and Technology. 2022; 15(11):4999-4. doi: 10.52711/0974-360X.2022.00840   Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-11-25


REFERENCES:
1.    “Drug profile for Lurasidone”, Available from: URL: https://www.drugbank.ca/drugs/DB08815
2.    Muvvala SS and Nadh RV, “Simple and Validated Ultraviolet Spectrophotometric Method for the Estimation of Lurasidone in Bulk Form.” Res. J. pharm. Bio. and chem. Sci. 2013,4, 609-617. doi: 10.4103/2230-973X.153390
3.    Polawar AR and Damle MC, “Development and Validation of RP-HPLC Method For Estimation of Lurasidone Hydrochloride In Bulk And Pharmaceutical Dosage Form.” Int. J. res. In pharm. and chem. 2014, 4, 327-332. doi: 10.13040/IJPSR.0975-8232.IJLSR.2 (2).17-22
4.    Patel BD, Bhavya M, Ankit BC. Method Development and Validation For Simultaneous Estimation of Lamivudine and Zidovudine in Tablet by Reverse-Phase High-Performance Liquid Chromatography. Asian Journal of Pharmaceutical and clinical Research. 2020 June; 13(6): 73-77. DOI: 10.47583/ijpsrr.2021.v69i02.019
5.    Krishana MR, Kumar SP, Khurdhus MK, Vaishnavi G, Mamatha M and Ravi K, “A Novel Spectrophotometric Method For The Estimation of Lurasidone In Pharmaceutical Dosage Forms.” World J. pharm. and pharm. Sci. 2017, 6, 964-970.
6.    Patel DM, Chaudhary AB and Patel BD. Development and validation of RP-HPLC method for simultaneous estimation Beclomethasone Dipropionate, Phenylephrine Hydrochloride and Lignocaine Hydrochloride in cream. World Journal of Pharmacy and Pharmaceutical Sciences. 2018 April; 7(5): 829-841. DOI: 10.47583/ijpsrr.2021.v69i02.019
7.    Patel Bhoomi; Patel Minal; Chaudhary Ankit. A Comprehensive and Comparative Study On regulations of Medical Countermeasures in USA and India. Journal of Emerging Technologies and Innovative Research. 2019; 6(5): 289-304. DOI: 10.47583/jetir.2019.v6i05.019.
8.    Joshi N-K, Shah N, Dumasiya M and Patel A. Development and Validation of Spectrophotometric Method for Estimation Of Lurasidone Hydrochloride: A Novel Antipsychotic Drug In Bulk And Pharmaceutical Dosage Form. J. Pharm. Sci. monitor. 2012, 4, 2643-2653. doi: 10.4103/2229-4708.103885.
9.    Patel BD, Chaudhary AB, Parmar PJ, Patel VN. Development and validation of reversed phase high performance liquid chromatography method for simultaneous estimation of Nebivolol HCl and Cilnidipine in combined tablet dosage form. Pharmaceutical and Biological Evaluations. 2016; 3(2): 208-214. DOI:04.01.2016/2016/575238.
10.    Trivedi Devanshi G; Chaudhary Ankit B; Patel Bhoomi D. Method Development and Validation for Estimation of Clotrimazole, Fusidic acid and Mometasone Furoate in Cream by RP-HPLC, World Journal of Pharmacy and Pharmaceutical Sciences. 2017 April; 6(5): 1204-1219. DOI: 10.20959/wjpps20175-9173.
11.    Suneetha A, Mansa K and Sindhura LS, “Stability Indicating Rp-Hplc Method for Determination and Validation of Lurasidone HCl in bulk and Pharmaceutical Dosage Forms.” J. chrom. 2015. DOI: 10.12991/mpj.2017.32.
12.    Rao BK, Ramu G, Rani PN and Rambabu C, “Assay of Lurasidone by a Stability Indicating RP-HPLC Method.” Ame. J. pharm. Tech. res. 2014, 4, 449-468. DOI: 10.12991/mpj.2017.32.
13.    Sangeetha RK, “Method Development and Validation For The Estimation of Lurasidone By RP-HPLC and HPTLC.” Eur. J. pharm. and med. Res. 2015, 2, 529-540. DOI: https://doi.org/10.22159/ijpps.2018v10i12.27895
14.    Patel KY and Patel SA, “Development and Validation of Reverse Phase High Performance Liquid Chromatography Method for Estimation of Lurasidone Hydrochloride in Synthetic Mixture.” Int. J. pharm. and drug anal. 2014, 2, 169-173. DOI: 10.12991/mpj.2017.32.
15.    Koo TS, Kim SJ, Lee J, Ha DJ, Baek M and Moon H, “Quantification of lurasidone, an atypical antipsychotic drug, in rat plasma with high-performance liquid chromatography with tandem mass spectrometry.” Biomed chrom. 2011, 25, 1389-1394. DOI: 10.1002/bmc.1625
16.    Patel BK, Chaudhary AB, Bhadani SM, Patel BD. Development and validation of stability indicating RP-HPLC method for simultaneous estimation of Aceclofenac and Cyclobenzaprine Hydrochloride in pharmaceutical dosage from. World Journal of Pharmacy and Pharmaceutical Sciences, 2018 April; 7(5): 874-888. Doi: 10.47583/ijpsrr.2021.v69i02.019.
17.    Bhoomi DP, Nidhi JD, Ankit C. Development and Validation of RP-HPLC Method for Estimation of Teneligliptin and its Impurity in Tablet. International Journal of Pharmaceutical Sciences Review and Research, 2021 August; 69(2): 127-133. DOI:10.47583/ijpsrr.2021.v69i02.019
18.    Vaja M. Patel B. Patel K. Chaudhary A. A Review on process validation of solid dosage form. 2021 July; 11(4): 157-160. DOI: http://dx.doi.org/10.22270/jddt.v11i4.4880.
19.    Sri KV, Shiva M and Sravani A, “Rapid RP-HPLC Method Development and Validation of Lurasidone Hydrochloride in Bulk and Tablet Form.” Indian Drugs. 2017, 54, 28-34. DOI: https://doi.org/10.22159/ijpps.2018v10i12.27895
20.    Patel BD, Chaudhary AB, Parmar PJ, Patel VN, “Development and Validation of Reversed Phase High Performance Liquid Chromatography method for simultaneous estimation of Nebivolol HCl and Cilnidipine in combined tablet dosage form.” Pharmaceutical and Biological Evaluations Journal. 2016, 2(3), 208-214. DOI: 10.1080/10408347.2020.1718483
21.    Charmy PD, Ankit BC, Bhoomi DP, “Development and validation of RP-HPLC method for simultaneous estimation of Saxagliptin and Dapagliflozin” World J. pharm. Res. 2018, 7(8), 803-812. Charmy PD, Ankit BC, Bhoomi DP, “Development and validation of RP-HPLC method for simultaneous estimation of Saxagliptin and Dapagliflozin” World J. pharm. Res. 2018, 7(8), 803-812.
22.    Jayshree P, Sandeep S, Santosh C, Sanjay K, “Development and Validation of RP-HPLC method for simultaneous Estimation of Metformin HCl and Gliclazide.” Asian Journal of Pharmaceutical Analysis. 2016, 6(3), 151-154. DOI: 10.5958/2231-5675.2016.00024.7.
23.    B. Thangabalan, M. Salomi, N. Sunitha, S. Manohar Babu, “Development of validated RP-HPLC method for the estimation of Itraconazole in pure and pharmaceutical dosage form.” Asian Journal of Pharmaceutical Analysis. 2013, 3(4), 119-123. DOI: 10.52711/2231-5675.2021.00031.
24.    K. Anandakumar, K. Varadharajan, T. Ayyappan, P.Nageswara Rao, K. Sujatha, “Estimation of Balsalazide in Bulk and in Formulation by UV-Visible Spectrophotometry.” Research Journal of Pharmacy and Technology. 2008, 1(4), 472-474. doi: 10.4103/2229-4708.72233
25.    Kumaraswamy G., J.M. Rajendrakumar, J.V.L.N. Sheshagirirao, U. Ashok Kumar, M. Arunadevi, “Spectrophotometric Determination of Tenatoprazole in Bulk Drug and Pharmaceutical Dosage Form.” Research Journal of Pharmacy and Technology. 2011, 4(4), 574-577. DOI: 10.52711/0974-360X.2021.00362
26.    Shubhangi V. Sutar, Veerendra C. Yeligar, “Degradation Kinetic Study of Melatonin in Alkaline and Acidic Medium by Validated Stability Indicating HPTLC Method” Research Journal of Pharmacy and Technology. 2020 13(2), 523-528. DOI: 10.5958/0974-360X.2020.00099.2
27.    Priyanka M. Pandya, Pankaj P. Kapupara, Ketan V. Shah, “Development and Validation of an Analytical Method for Simultaneous Estimation of Clotrimazole and its Impurity by RP-HPLC.” Research Journal of Pharmacy and Technology.2018, 11(3), 894-898. DOI: 10.5958/0974-360X.2020.00758.1
28.    Sanjeshkumar GR, Sejal AZ, Maulikkumar DV, Sohansinh SV, “Formulation and Evaluation of Spherical Crystal Agglomerates of Lurasidone Hydrochloride” Research Journal of Pharmacy and Technology. 2021. 14(3), 1238-1246. DOI: 10.5958/0974-360X.2021.00220.1
29.    Dwivedi Abha, Kaushik Avinash, Sharma Ganesh N., Akhtar Javed, “Impurity Profiling With Use of Hyphenated Techniques.” Asian Journal of Research in Chemistry. 2012, 5(7), 875-881. DOI: 10.1080/10408347.2020.1718483
30.    Mitali A. Patel, Niraj Vyas, “Development and Validation of Stability Indicating HPTLC Method for Estimation of Ursolic Acid.” Asian Journal of Research in Chemistry. 2013, 6(6), 546-551. DOI: 10.1080/10408347.2020.1718483
31.    G. Saravanan, Md. Yunoos, Ch. Swapna Latha, “Development and validation of RP-HPLC method for simultaneous estimation of Tapentadol and Paracetamol in bulk and combined dosage form.” Journal of Research in Chemistry. 2014, 7(2), 220-224.
32.    ICH, Validation of Analytical Procedures; Methodology, Q2 (R1), International Conference on Harmonization, IFPMA, Geneva 1996.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available